CIP
SURF

Cornerstone Investment Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Cornerstone Investment Partners’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,300
Closed -$166K – 327
2021
Q2 		$166K Hold
22,300
– – 0.01% 285
2021
Q1 		$174K Hold
22,300
– – 0.01% 258
2020
Q4 		$206K Hold
22,300
– – 0.01% 165
2020
Q3 		$154K Buy
22,300
+1,300
+6% +$7.89K 0.01% 130
2020
Q2 		$138K Buy
+21,000
New +$75.8K 0.01% 151

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone Investment Partners's SURF Position: Q3 2021 in Review

Cornerstone Investment Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2021, closing a stake of 22,300 shares — an estimated $166K sold.

Cornerstone Investment Partners first reported a position in SURF in Q2 2020 and held it in 5 quarters. The position peaked at $206K in Q4 2020. 91 funds tracked by Wall St. Rank hold SURF as of Q3 2021.

  • Cornerstone Investment Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Cornerstone Investment Partners sold 22,300 Surface Oncology, Inc. Common Stock shares in Q3 2021, an estimated $166K.
  • Cornerstone Investment Partners first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Cornerstone Investment Partners's Surface Oncology, Inc. Common Stock position peaked at $206K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2021.

Based on Cornerstone Investment Partners's 13F filing for Q3 2021, filed 25 Oct 2021.